Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver Transplantation
Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin Used in Combination With Lamivudine
Status: Enrolling
Updated:  12/31/1969
University of Florida
mi
from
Gainesville, FL
Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver Transplantation
Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin Used in Combination With Lamivudine
Status: Enrolling
Updated: 12/31/1969
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver Transplantation
Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin Used in Combination With Lamivudine
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver Transplantation
Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin Used in Combination With Lamivudine
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver Transplantation
Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin Used in Combination With Lamivudine
Status: Enrolling
Updated:  12/31/1969
Jackson Memorial Hospital/University of Miami
mi
from
Miami, FL
Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver Transplantation
Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin Used in Combination With Lamivudine
Status: Enrolling
Updated: 12/31/1969
Jackson Memorial Hospital/University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver Transplantation
Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin Used in Combination With Lamivudine
Status: Enrolling
Updated:  12/31/1969
Rush-Presbyterian-St. Luke's Medical Center
mi
from
Chicago, IL
Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver Transplantation
Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin Used in Combination With Lamivudine
Status: Enrolling
Updated: 12/31/1969
Rush-Presbyterian-St. Luke's Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver Transplantation
Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin Used in Combination With Lamivudine
Status: Enrolling
Updated:  12/31/1969
University of Michigan Health System
mi
from
Ann Arbor, MI
Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver Transplantation
Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin Used in Combination With Lamivudine
Status: Enrolling
Updated: 12/31/1969
University of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver Transplantation
Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin Used in Combination With Lamivudine
Status: Enrolling
Updated:  12/31/1969
Rochester Methodist Hospital
mi
from
Rochester, MN
Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver Transplantation
Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin Used in Combination With Lamivudine
Status: Enrolling
Updated: 12/31/1969
Rochester Methodist Hospital
mi
from
Rochester, MN
Click here to add this to my saved trials
Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver Transplantation
Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin Used in Combination With Lamivudine
Status: Enrolling
Updated:  12/31/1969
Mount Sinai Hospital
mi
from
New York, NY
Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver Transplantation
Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin Used in Combination With Lamivudine
Status: Enrolling
Updated: 12/31/1969
Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver Transplantation
Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin Used in Combination With Lamivudine
Status: Enrolling
Updated:  12/31/1969
New York-Presbyterian Hospital Columbia-Presbyterian Medical Center
mi
from
New York, NY
Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver Transplantation
Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin Used in Combination With Lamivudine
Status: Enrolling
Updated: 12/31/1969
New York-Presbyterian Hospital Columbia-Presbyterian Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver Transplantation
Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin Used in Combination With Lamivudine
Status: Enrolling
Updated:  12/31/1969
University of North Carolina Hospitals
mi
from
Chapel Hill, NC
Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver Transplantation
Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin Used in Combination With Lamivudine
Status: Enrolling
Updated: 12/31/1969
University of North Carolina Hospitals
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver Transplantation
Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin Used in Combination With Lamivudine
Status: Enrolling
Updated:  12/31/1969
Medical College of Virginia Commenwealth University
mi
from
Richmond, VA
Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver Transplantation
Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin Used in Combination With Lamivudine
Status: Enrolling
Updated: 12/31/1969
Medical College of Virginia Commenwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Safety and Compliance of Taking Mesalamine Once a Day in Pediatric Patients
A Randomized Trial Comparing Once Daily Dosing vs. Multiple Doses a Day of Mesalamine in Pediatric Patients With Quiescent Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Morristown Memorial Hospital/Goyerb Children's Hospital
mi
from
Morristown, NJ
Safety and Compliance of Taking Mesalamine Once a Day in Pediatric Patients
A Randomized Trial Comparing Once Daily Dosing vs. Multiple Doses a Day of Mesalamine in Pediatric Patients With Quiescent Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Morristown Memorial Hospital/Goyerb Children's Hospital
mi
from
Morristown, NJ
Click here to add this to my saved trials
A Study to Evaluate BMS-986165 Tablet Formulation Relative to BMS-986165 Capsule Formulation and the Effect of a High-Fat/ High-Calorie Meal and Increased Gastric pH on the BMS-986165 Tablet Formulation
A Phase 1, Randomized, Open-Label, Single-Dose, Crossover Study To Evaluate the Bioavailability of BMS-986165 Tablet Formulation Relative To BMS-986165 Capsule Formulation and the Effect of a High-Fat/ High-Calorie Meal And Increased Gastric pH on the Bioavailability of BMS-986165 Tablet Formulation in Healthy Subjects
Status: Enrolling
Updated:  12/31/1969
PRA Health Sciences
mi
from
Salt Lake City, UT
A Study to Evaluate BMS-986165 Tablet Formulation Relative to BMS-986165 Capsule Formulation and the Effect of a High-Fat/ High-Calorie Meal and Increased Gastric pH on the BMS-986165 Tablet Formulation
A Phase 1, Randomized, Open-Label, Single-Dose, Crossover Study To Evaluate the Bioavailability of BMS-986165 Tablet Formulation Relative To BMS-986165 Capsule Formulation and the Effect of a High-Fat/ High-Calorie Meal And Increased Gastric pH on the Bioavailability of BMS-986165 Tablet Formulation in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
PRA Health Sciences
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Inflammatory Mediators as Potential Non-Invasive Biomarkers in Subjects With Eosinophilic Esophagitis
Inflammatory Mediators as Potential Non-Invasive Biomarkers and Understanding the Mechanism of Remodeling in Tissue Biopsies in Subjects With Eosinophilic Esophagitis: A Pilot Study
Status: Enrolling
Updated:  12/31/1969
Ann & Robert H Lurie Childjren's Hospital of Chicago
mi
from
Chicago, IL
Inflammatory Mediators as Potential Non-Invasive Biomarkers in Subjects With Eosinophilic Esophagitis
Inflammatory Mediators as Potential Non-Invasive Biomarkers and Understanding the Mechanism of Remodeling in Tissue Biopsies in Subjects With Eosinophilic Esophagitis: A Pilot Study
Status: Enrolling
Updated: 12/31/1969
Ann & Robert H Lurie Childjren's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Inflammatory Mediators as Potential Non-Invasive Biomarkers in Subjects With Eosinophilic Esophagitis
Inflammatory Mediators as Potential Non-Invasive Biomarkers and Understanding the Mechanism of Remodeling in Tissue Biopsies in Subjects With Eosinophilic Esophagitis: A Pilot Study
Status: Enrolling
Updated:  12/31/1969
University of Illinois at Chicago (UIC)
mi
from
Chicago, IL
Inflammatory Mediators as Potential Non-Invasive Biomarkers in Subjects With Eosinophilic Esophagitis
Inflammatory Mediators as Potential Non-Invasive Biomarkers and Understanding the Mechanism of Remodeling in Tissue Biopsies in Subjects With Eosinophilic Esophagitis: A Pilot Study
Status: Enrolling
Updated: 12/31/1969
University of Illinois at Chicago (UIC)
mi
from
Chicago, IL
Click here to add this to my saved trials
Study Assessing Risk Factors for Abdominal Pain in Children With Inflammatory Bowel Disease
A Pilot Study Assessing Risk Factors for Abdominal Pain in Children With Inflammatory Bowel Disease: The ALLAY Study
Status: Enrolling
Updated:  12/31/1969
CT Children's Medical Center
mi
from
Hartford, CT
Study Assessing Risk Factors for Abdominal Pain in Children With Inflammatory Bowel Disease
A Pilot Study Assessing Risk Factors for Abdominal Pain in Children With Inflammatory Bowel Disease: The ALLAY Study
Status: Enrolling
Updated: 12/31/1969
CT Children's Medical Center
mi
from
Hartford, CT
Click here to add this to my saved trials
Effect of Dietary Macronutrient Composition
Effect of Dietary Macronutrient Composition on Liver Substrate Metabolism
Status: Enrolling
Updated:  12/31/1969
Center for Human Nutrition
mi
from
Dallas, TX
Effect of Dietary Macronutrient Composition
Effect of Dietary Macronutrient Composition on Liver Substrate Metabolism
Status: Enrolling
Updated: 12/31/1969
Center for Human Nutrition
mi
from
Dallas, TX
Click here to add this to my saved trials
OCR002-SP103 - Oral Immediate Release Study
An Open-Label, Two-Part, Phase 1/2a, Crossover Study to Determine the Absolute Bioavailability and Pharmacokinetics of Oral Immediate-Release Doses of OCR‑002 in Subjects With Varying Degrees of Cirrhosis
Status: Enrolling
Updated:  12/31/1969
Southern California Research Center
mi
from
Coronado, CA
OCR002-SP103 - Oral Immediate Release Study
An Open-Label, Two-Part, Phase 1/2a, Crossover Study to Determine the Absolute Bioavailability and Pharmacokinetics of Oral Immediate-Release Doses of OCR‑002 in Subjects With Varying Degrees of Cirrhosis
Status: Enrolling
Updated: 12/31/1969
Southern California Research Center
mi
from
Coronado, CA
Click here to add this to my saved trials
Dose Ranging Study With the Probiotic Combination (VSL#3) in Diarrhea IBS
A Randomized, Multi-center, Double-blind, Placebo Controlled, Dose Ranging Study With VSL#3 in Diarrhea Predominant IBS Patients
Status: Enrolling
Updated:  12/31/1969
BIDMC
mi
from
Boston, MA
Dose Ranging Study With the Probiotic Combination (VSL#3) in Diarrhea IBS
A Randomized, Multi-center, Double-blind, Placebo Controlled, Dose Ranging Study With VSL#3 in Diarrhea Predominant IBS Patients
Status: Enrolling
Updated: 12/31/1969
BIDMC
mi
from
Boston, MA
Click here to add this to my saved trials
The Evaluation of Patients With Esophageal and Foregut Disorders With WATS (Wide Area Transepithelial Sample With 3-Dimensional Computer-Assisted Analysis) vs. 4-Quadrant Forceps Biopsy
The Evaluation of Patients With Esophageal and Foregut Disorders With WATS (Wide Area Transepithelial Sample With 3-Dimensional Computer-Assisted Analysis) vs. 4-Quadrant Forceps Biopsy
Status: Enrolling
Updated:  12/31/1969
Providence Portland Medical Center
mi
from
Portland, OR
The Evaluation of Patients With Esophageal and Foregut Disorders With WATS (Wide Area Transepithelial Sample With 3-Dimensional Computer-Assisted Analysis) vs. 4-Quadrant Forceps Biopsy
The Evaluation of Patients With Esophageal and Foregut Disorders With WATS (Wide Area Transepithelial Sample With 3-Dimensional Computer-Assisted Analysis) vs. 4-Quadrant Forceps Biopsy
Status: Enrolling
Updated: 12/31/1969
Providence Portland Medical Center
mi
from
Portland, OR
Click here to add this to my saved trials
Safety, Tolerability, and Pharmacokinetics of Oral BT-11 in Healthy Adult Male and Female Volunteers
A Randomized, Placebo-Controlled, Sequential Single and Multiple Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral BT-11 in Healthy Adult Male and Female Volunteers
Status: Enrolling
Updated:  12/31/1969
Landos Biopharma Inc.
mi
from
Blacksburg, VA
Safety, Tolerability, and Pharmacokinetics of Oral BT-11 in Healthy Adult Male and Female Volunteers
A Randomized, Placebo-Controlled, Sequential Single and Multiple Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral BT-11 in Healthy Adult Male and Female Volunteers
Status: Enrolling
Updated: 12/31/1969
Landos Biopharma Inc.
mi
from
Blacksburg, VA
Click here to add this to my saved trials
Feasibility of VIIT in Adults With NASH
Feasibility of Vigorous-Intensity Interval Training in Adults With Nonalcoholic Steatohepatitis
Status: Enrolling
Updated:  12/31/1969
Duke Integrative Medicine
mi
from
Durham, NC
Feasibility of VIIT in Adults With NASH
Feasibility of Vigorous-Intensity Interval Training in Adults With Nonalcoholic Steatohepatitis
Status: Enrolling
Updated: 12/31/1969
Duke Integrative Medicine
mi
from
Durham, NC
Click here to add this to my saved trials
Comparison of Standard and Endoscope Assisted Endotracheal Intubation
Comparison of Standard Endotracheal Intubation [SEI] and Endoscope Assisted Endotracheal Intubation [EAE]
Status: Enrolling
Updated:  12/31/1969
Stanford Univ Med Ctr
mi
from
Stanford, CA
Comparison of Standard and Endoscope Assisted Endotracheal Intubation
Comparison of Standard Endotracheal Intubation [SEI] and Endoscope Assisted Endotracheal Intubation [EAE]
Status: Enrolling
Updated: 12/31/1969
Stanford Univ Med Ctr
mi
from
Stanford, CA
Click here to add this to my saved trials
Plastic Stents Compared With Metal Stents in Treating Patients With Malignant Dysphagia Caused by Esophageal Cancer or Gastroesophageal Junction Cancer
A Quality of Life Comparison in Patients With Malignant Dysphagia Treated With Either Self-Expanding Plastic Stents (SEPS) or Self-Expanding Metal Stents (SEMS)
Status: Enrolling
Updated:  12/31/1969
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Plastic Stents Compared With Metal Stents in Treating Patients With Malignant Dysphagia Caused by Esophageal Cancer or Gastroesophageal Junction Cancer
A Quality of Life Comparison in Patients With Malignant Dysphagia Treated With Either Self-Expanding Plastic Stents (SEPS) or Self-Expanding Metal Stents (SEMS)
Status: Enrolling
Updated: 12/31/1969
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Vascepa to Accelerate Lipoprotein Uptake and Elimination
Vascepa to Accelerate Lipoprotein Uptake and Elimination (VALUE): An Open-Label, Mechanistic, Randomized, Controlled, Single-Center Trial of AMR101 in Patients With Dyslipidemia
Status: Enrolling
Updated:  12/31/1969
Perelman School of Medicine, University of Pennsylvania
mi
from
Philadelphia, PA
Vascepa to Accelerate Lipoprotein Uptake and Elimination
Vascepa to Accelerate Lipoprotein Uptake and Elimination (VALUE): An Open-Label, Mechanistic, Randomized, Controlled, Single-Center Trial of AMR101 in Patients With Dyslipidemia
Status: Enrolling
Updated: 12/31/1969
Perelman School of Medicine, University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Fecal Microbiota Transplantation to Treat Recurrent C. Difficile Associated Diarrhea Via Retention Enema or Oral Route
A Study of Fecal Microbiota Transplantation (FMT) for the Treatment of Recurrent C. Difficile Associated Diarrhea (RCDAD) Via Retention Enema or Oral Route
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center at Housotn
mi
from
Houston, TX
Fecal Microbiota Transplantation to Treat Recurrent C. Difficile Associated Diarrhea Via Retention Enema or Oral Route
A Study of Fecal Microbiota Transplantation (FMT) for the Treatment of Recurrent C. Difficile Associated Diarrhea (RCDAD) Via Retention Enema or Oral Route
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center at Housotn
mi
from
Houston, TX
Click here to add this to my saved trials
Total Parenteral Nutrition-Associated Liver Disease
Prevention of TPN-Associated Hepatic Steatosis: A Placebo Controlled Trial
Status: Enrolling
Updated:  6/23/2005
Northwestern University
mi
from
Chicago, IL
Total Parenteral Nutrition-Associated Liver Disease
Prevention of TPN-Associated Hepatic Steatosis: A Placebo Controlled Trial
Status: Enrolling
Updated: 6/23/2005
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Integrating Buprenorphine Into HIV Treatment
SPNS Buprenorphine and Integrated HIV Care Evaluation and Support Center: Integration of Buprenorphine and HIV Treatment Using the OASIS Model
Status: Enrolling
Updated:  10/24/2005
Alameda County Medical Center HIV Clinic
mi
from
Oakland, CA
Integrating Buprenorphine Into HIV Treatment
SPNS Buprenorphine and Integrated HIV Care Evaluation and Support Center: Integration of Buprenorphine and HIV Treatment Using the OASIS Model
Status: Enrolling
Updated: 10/24/2005
Alameda County Medical Center HIV Clinic
mi
from
Oakland, CA
Click here to add this to my saved trials
Integrating Buprenorphine Into HIV Treatment
SPNS Buprenorphine and Integrated HIV Care Evaluation and Support Center: Integration of Buprenorphine and HIV Treatment Using the OASIS Model
Status: Enrolling
Updated:  10/24/2005
OASIS
mi
from
Oakland, CA
Integrating Buprenorphine Into HIV Treatment
SPNS Buprenorphine and Integrated HIV Care Evaluation and Support Center: Integration of Buprenorphine and HIV Treatment Using the OASIS Model
Status: Enrolling
Updated: 10/24/2005
OASIS
mi
from
Oakland, CA
Click here to add this to my saved trials
Integrating Buprenorphine Into HIV Treatment
SPNS Buprenorphine and Integrated HIV Care Evaluation and Support Center: Integration of Buprenorphine and HIV Treatment Using the OASIS Model
Status: Enrolling
Updated:  10/24/2005
Fairmont Hospital HIV Clinic
mi
from
San Leandro, CA
Integrating Buprenorphine Into HIV Treatment
SPNS Buprenorphine and Integrated HIV Care Evaluation and Support Center: Integration of Buprenorphine and HIV Treatment Using the OASIS Model
Status: Enrolling
Updated: 10/24/2005
Fairmont Hospital HIV Clinic
mi
from
San Leandro, CA
Click here to add this to my saved trials
Electrogastrogram (EGG) Reproducibility Study: EEG Readings in Normal Subjects and Dyspeptic Patients
Reproducibility and Inter-Reader Reliability of Electrogastrographic Readings in Normal Subjects and Dyspeptic Patients
Status: Enrolling
Updated:  2/6/2006
Temple University School of Medicine
mi
from
Philadelphia, PA
Electrogastrogram (EGG) Reproducibility Study: EEG Readings in Normal Subjects and Dyspeptic Patients
Reproducibility and Inter-Reader Reliability of Electrogastrographic Readings in Normal Subjects and Dyspeptic Patients
Status: Enrolling
Updated: 2/6/2006
Temple University School of Medicine
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Tricyclic Antidepressants (TCAs) on Gastric Emptying
Effect of Tricyclic Antidepressant Agents on Gastric Accommodation and Emptying
Status: Enrolling
Updated:  2/8/2006
Temple University School of Medicine
mi
from
Philadelphia, PA
Tricyclic Antidepressants (TCAs) on Gastric Emptying
Effect of Tricyclic Antidepressant Agents on Gastric Accommodation and Emptying
Status: Enrolling
Updated: 2/8/2006
Temple University School of Medicine
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASH
The Effect of Pentoxifylline on Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  2/9/2006
Northwestern University
mi
from
Chicago, IL
Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASH
The Effect of Pentoxifylline on Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 2/9/2006
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Radiofrequency Nucleoplasty Vs Percutaneous Nucleotomy (Dekompressor) Vs Decompression Catheter for the Treatment of Painful Contained Lumbar Disc Herniation
Radiofrequency Nucleoplasty Vs Percutaneous Nucleotomy (Dekompressor) Vs Decompression Catheter for the Treatment of Painful Contained Lumbar Disc Herniation: A Prospective Randomized Controlled Study
Status: Enrolling
Updated:  3/8/2006
The Cleveland Clinic - Pain Management Department
mi
from
Cleveland, OH
Radiofrequency Nucleoplasty Vs Percutaneous Nucleotomy (Dekompressor) Vs Decompression Catheter for the Treatment of Painful Contained Lumbar Disc Herniation
Radiofrequency Nucleoplasty Vs Percutaneous Nucleotomy (Dekompressor) Vs Decompression Catheter for the Treatment of Painful Contained Lumbar Disc Herniation: A Prospective Randomized Controlled Study
Status: Enrolling
Updated: 3/8/2006
The Cleveland Clinic - Pain Management Department
mi
from
Cleveland, OH
Click here to add this to my saved trials
Feasibility Study of Phototherapy System to Treat H Pylori
Phase 1 Study of Phototherapy System to Treat H Pylori
Status: Enrolling
Updated:  9/19/2006
Beth Israel Deaconness Medical Center
mi
from
Boston, MA
Feasibility Study of Phototherapy System to Treat H Pylori
Phase 1 Study of Phototherapy System to Treat H Pylori
Status: Enrolling
Updated: 9/19/2006
Beth Israel Deaconness Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Feasibility Study of Phototherapy System to Treat H Pylori
Phase 1 Study of Phototherapy System to Treat H Pylori
Status: Enrolling
Updated:  9/19/2006
Umass Memorial Medical Center
mi
from
Worcester, MA
Feasibility Study of Phototherapy System to Treat H Pylori
Phase 1 Study of Phototherapy System to Treat H Pylori
Status: Enrolling
Updated: 9/19/2006
Umass Memorial Medical Center
mi
from
Worcester, MA
Click here to add this to my saved trials
Feasibility Study of Phototherapy System to Treat H Pylori
Phase 1 Study of Phototherapy System to Treat H Pylori
Status: Enrolling
Updated:  9/19/2006
Abbott Northwestern Hospital
mi
from
Minneapolis, MN
Feasibility Study of Phototherapy System to Treat H Pylori
Phase 1 Study of Phototherapy System to Treat H Pylori
Status: Enrolling
Updated: 9/19/2006
Abbott Northwestern Hospital
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Prevention of Atrial Fibrillation Following Esophagectomy
Prevention of Atrial Fibrillation Following Thoracoabdominal Esophagectomy Surgery
Status: Enrolling
Updated:  1/8/2007
Indiana University Hospital
mi
from
Indianapolis, IN
Prevention of Atrial Fibrillation Following Esophagectomy
Prevention of Atrial Fibrillation Following Thoracoabdominal Esophagectomy Surgery
Status: Enrolling
Updated: 1/8/2007
Indiana University Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Buprenorphine and Integrated HIV Care Evaluation
An Evaluation of Innovative Methods for Integrating Buprenorphine Opioid Treatment in HIV Primary Care Settings
Status: Enrolling
Updated:  3/23/2007
El Rio Santa Cruz Neighborhood Health Center
mi
from
Tucson, AZ
Buprenorphine and Integrated HIV Care Evaluation
An Evaluation of Innovative Methods for Integrating Buprenorphine Opioid Treatment in HIV Primary Care Settings
Status: Enrolling
Updated: 3/23/2007
El Rio Santa Cruz Neighborhood Health Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Buprenorphine and Integrated HIV Care Evaluation
An Evaluation of Innovative Methods for Integrating Buprenorphine Opioid Treatment in HIV Primary Care Settings
Status: Enrolling
Updated:  3/23/2007
Organization to Achieve Solutions in Substance Abuse
mi
from
Oakland, CA
Buprenorphine and Integrated HIV Care Evaluation
An Evaluation of Innovative Methods for Integrating Buprenorphine Opioid Treatment in HIV Primary Care Settings
Status: Enrolling
Updated: 3/23/2007
Organization to Achieve Solutions in Substance Abuse
mi
from
Oakland, CA
Click here to add this to my saved trials
Buprenorphine and Integrated HIV Care Evaluation
An Evaluation of Innovative Methods for Integrating Buprenorphine Opioid Treatment in HIV Primary Care Settings
Status: Enrolling
Updated:  3/23/2007
University of California at San Francisco
mi
from
San Francisco, CA
Buprenorphine and Integrated HIV Care Evaluation
An Evaluation of Innovative Methods for Integrating Buprenorphine Opioid Treatment in HIV Primary Care Settings
Status: Enrolling
Updated: 3/23/2007
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Buprenorphine and Integrated HIV Care Evaluation
An Evaluation of Innovative Methods for Integrating Buprenorphine Opioid Treatment in HIV Primary Care Settings
Status: Enrolling
Updated:  3/23/2007
Yale University School of Medicine AIDS Program
mi
from
New Haven, CT
Buprenorphine and Integrated HIV Care Evaluation
An Evaluation of Innovative Methods for Integrating Buprenorphine Opioid Treatment in HIV Primary Care Settings
Status: Enrolling
Updated: 3/23/2007
Yale University School of Medicine AIDS Program
mi
from
New Haven, CT
Click here to add this to my saved trials
Buprenorphine and Integrated HIV Care Evaluation
An Evaluation of Innovative Methods for Integrating Buprenorphine Opioid Treatment in HIV Primary Care Settings
Status: Enrolling
Updated:  3/23/2007
University of Miami School of Medicine
mi
from
Miami, FL
Buprenorphine and Integrated HIV Care Evaluation
An Evaluation of Innovative Methods for Integrating Buprenorphine Opioid Treatment in HIV Primary Care Settings
Status: Enrolling
Updated: 3/23/2007
University of Miami School of Medicine
mi
from
Miami, FL
Click here to add this to my saved trials
Buprenorphine and Integrated HIV Care Evaluation
An Evaluation of Innovative Methods for Integrating Buprenorphine Opioid Treatment in HIV Primary Care Settings
Status: Enrolling
Updated:  3/23/2007
The CORE Ctr
mi
from
Chicago, IL
Buprenorphine and Integrated HIV Care Evaluation
An Evaluation of Innovative Methods for Integrating Buprenorphine Opioid Treatment in HIV Primary Care Settings
Status: Enrolling
Updated: 3/23/2007
The CORE Ctr
mi
from
Chicago, IL
Click here to add this to my saved trials
Buprenorphine and Integrated HIV Care Evaluation
An Evaluation of Innovative Methods for Integrating Buprenorphine Opioid Treatment in HIV Primary Care Settings
Status: Enrolling
Updated:  3/23/2007
Johns Hopkins University
mi
from
Baltimore, MD
Buprenorphine and Integrated HIV Care Evaluation
An Evaluation of Innovative Methods for Integrating Buprenorphine Opioid Treatment in HIV Primary Care Settings
Status: Enrolling
Updated: 3/23/2007
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Buprenorphine and Integrated HIV Care Evaluation
An Evaluation of Innovative Methods for Integrating Buprenorphine Opioid Treatment in HIV Primary Care Settings
Status: Enrolling
Updated:  3/23/2007
Montefiore Medical Center
mi
from
New York, NY
Buprenorphine and Integrated HIV Care Evaluation
An Evaluation of Innovative Methods for Integrating Buprenorphine Opioid Treatment in HIV Primary Care Settings
Status: Enrolling
Updated: 3/23/2007
Montefiore Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Buprenorphine and Integrated HIV Care Evaluation
An Evaluation of Innovative Methods for Integrating Buprenorphine Opioid Treatment in HIV Primary Care Settings
Status: Enrolling
Updated:  3/23/2007
Oregon Health and Science University
mi
from
Portland, OR
Buprenorphine and Integrated HIV Care Evaluation
An Evaluation of Innovative Methods for Integrating Buprenorphine Opioid Treatment in HIV Primary Care Settings
Status: Enrolling
Updated: 3/23/2007
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Buprenorphine and Integrated HIV Care Evaluation
An Evaluation of Innovative Methods for Integrating Buprenorphine Opioid Treatment in HIV Primary Care Settings
Status: Enrolling
Updated:  3/23/2007
Miriam Hospital
mi
from
Providence, RI
Buprenorphine and Integrated HIV Care Evaluation
An Evaluation of Innovative Methods for Integrating Buprenorphine Opioid Treatment in HIV Primary Care Settings
Status: Enrolling
Updated: 3/23/2007
Miriam Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
TRIAD Burden of Illness Mucositis Study
Risk and Outcomes of Mucositis in Subjects Being Treated for Breast, Colorectal, Head and Neck, Non-Small Cell Lung Cancers or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated:  4/19/2007
Univeristy Of Wisconsin
mi
from
Madison, WI
TRIAD Burden of Illness Mucositis Study
Risk and Outcomes of Mucositis in Subjects Being Treated for Breast, Colorectal, Head and Neck, Non-Small Cell Lung Cancers or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 4/19/2007
Univeristy Of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Study to Assess the Use of a Simple Lab Test to Screen for Rickets in Children
The Feasibility of Assessing the Prevalence of Rickets in Children
Status: Enrolling
Updated:  7/17/2007
Univ of Washington
mi
from
Seattle, WA
Study to Assess the Use of a Simple Lab Test to Screen for Rickets in Children
The Feasibility of Assessing the Prevalence of Rickets in Children
Status: Enrolling
Updated: 7/17/2007
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Treatment of Crohn's Disease With an Antibiotic Regimen Directed Against Mycobacterium Avium Paratuberculosis
Treatment of Crohn's Disease With an Antibiotic Regimen Directed Against Mycobacterium Avium Paratuberculosis
Status: Enrolling
Updated:  8/7/2007
MedStar Washington Hospital Center
mi
from
Washington,
Treatment of Crohn's Disease With an Antibiotic Regimen Directed Against Mycobacterium Avium Paratuberculosis
Treatment of Crohn's Disease With an Antibiotic Regimen Directed Against Mycobacterium Avium Paratuberculosis
Status: Enrolling
Updated: 8/7/2007
MedStar Washington Hospital Center
mi
from
Washington,
Click here to add this to my saved trials